(1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine

Catalog No. :
ACMRWZ697
CAS No. :
267876-25-5
Molecular Formula :
C8H9N3
Molecular Weight :
147.18

IUPAC Name:(1H-pyrrolo[2,3-b]pyridin-5-yl)methanamine

(1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$106.00Login to see priceIn stockInquiry
250mg98%$181.00Login to see priceIn stockInquiry
1g98%$451.00Login to see priceIn stockInquiry
5g98%$1170.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine
IUPAC Name(1H-pyrrolo[2,3-b]pyridin-5-yl)methanamine
MDL No.MFCD09475794
Molecular FormulaC8H9N3
Molecular Weight147.18
SMILESNCC1=CN=C(NC=C2)C2=C1
InChI KeyQIPKJJHSPMUFFY-UHFFFAOYSA-N
Synonym267876-25-5 | 1H-PYRROLO[2,3-B]PYRIDINE-5-METHANAMINE | 1H-pyrrolo[2,3-b]pyridin-5-ylmethanamine | (1H-PYRROLO[2,3-B]PYRIDIN-5-YL)METHANAMINE | MFCD09475794 | SCHEMBL1869919 | DTXSID50477480 | AKOS006332416 | CS-W009116 | DS-8845 | PB32730 | SY097167 | FT-0684777 | P10728 | 1-(1H-Py
CAS No.267876-25-5
PubChem CID12096224

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACMRWZ697 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACANXG531 route compound structure diagram
    ACANXG531517918-95-5 In Stock
  2. Then
  3. ACMRWZ697 route product structure diagram
    ACMRWZ697267876-25-5 In Stock
Inquiry

2. ACMRWZ697 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. ACQLIY364 route compound structure diagram
    ACQLIY364849067-90-9 In Stock
  4. Then
  5. ACMRWZ697 route product structure diagram
    ACMRWZ697267876-25-5 In Stock
Inquiry

Comments (0)